nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0527	0.0527	CcSEcCtD
Anagrelide—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.0475	0.0475	CcSEcCtD
Anagrelide—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0399	0.0399	CcSEcCtD
Anagrelide—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.024	0.024	CcSEcCtD
Anagrelide—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0198	CcSEcCtD
Anagrelide—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0192	CcSEcCtD
Anagrelide—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0187	CcSEcCtD
Anagrelide—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0184	CcSEcCtD
Anagrelide—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0166	CcSEcCtD
Anagrelide—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0152	CcSEcCtD
Anagrelide—Injury—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0145	CcSEcCtD
Anagrelide—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0141	CcSEcCtD
Anagrelide—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Anagrelide—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Anagrelide—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Anagrelide—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Anagrelide—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Anagrelide—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Anagrelide—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Anagrelide—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Anagrelide—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Anagrelide—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Anagrelide—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Anagrelide—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Anagrelide—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0112	CcSEcCtD
Anagrelide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0108	CcSEcCtD
Anagrelide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Anagrelide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Anagrelide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Anagrelide—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Anagrelide—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Anagrelide—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Anagrelide—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Anagrelide—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Anagrelide—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Anagrelide—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Anagrelide—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00987	0.00987	CcSEcCtD
Anagrelide—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00982	0.00982	CcSEcCtD
Anagrelide—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00971	0.00971	CcSEcCtD
Anagrelide—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00966	0.00966	CcSEcCtD
Anagrelide—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00927	0.00927	CcSEcCtD
Anagrelide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00924	0.00924	CcSEcCtD
Anagrelide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0092	0.0092	CcSEcCtD
Anagrelide—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00917	0.00917	CcSEcCtD
Anagrelide—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00911	0.00911	CcSEcCtD
Anagrelide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00891	0.00891	CcSEcCtD
Anagrelide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00862	0.00862	CcSEcCtD
Anagrelide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00826	0.00826	CcSEcCtD
Anagrelide—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00817	0.00817	CcSEcCtD
Anagrelide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00793	0.00793	CcSEcCtD
Anagrelide—Tension—Hydrochlorothiazide—nephrolithiasis	0.0079	0.0079	CcSEcCtD
Anagrelide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00782	0.00782	CcSEcCtD
Anagrelide—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00778	CcSEcCtD
Anagrelide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00774	0.00774	CcSEcCtD
Anagrelide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00758	CcSEcCtD
Anagrelide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00747	0.00747	CcSEcCtD
Anagrelide—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00744	0.00744	CcSEcCtD
Anagrelide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00726	0.00726	CcSEcCtD
Anagrelide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00722	0.00722	CcSEcCtD
Anagrelide—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00711	0.00711	CcSEcCtD
Anagrelide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00707	0.00707	CcSEcCtD
Anagrelide—Cough—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00702	CcSEcCtD
Anagrelide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00685	0.00685	CcSEcCtD
Anagrelide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00685	0.00685	CcSEcCtD
Anagrelide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00685	0.00685	CcSEcCtD
Anagrelide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00677	0.00677	CcSEcCtD
Anagrelide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0067	0.0067	CcSEcCtD
Anagrelide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00662	0.00662	CcSEcCtD
Anagrelide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00657	0.00657	CcSEcCtD
Anagrelide—Shock—Hydrochlorothiazide—nephrolithiasis	0.00646	0.00646	CcSEcCtD
Anagrelide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00643	CcSEcCtD
Anagrelide—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00641	0.00641	CcSEcCtD
Anagrelide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00635	0.00635	CcSEcCtD
Anagrelide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00626	CcSEcCtD
Anagrelide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00614	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00598	CcSEcCtD
Anagrelide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00594	CcSEcCtD
Anagrelide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0059	CcSEcCtD
Anagrelide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00585	CcSEcCtD
Anagrelide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00584	CcSEcCtD
Anagrelide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00578	CcSEcCtD
Anagrelide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00571	0.00571	CcSEcCtD
Anagrelide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00566	CcSEcCtD
Anagrelide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00562	CcSEcCtD
Anagrelide—Pain—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00562	CcSEcCtD
Anagrelide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00541	CcSEcCtD
Anagrelide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00537	CcSEcCtD
Anagrelide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00522	CcSEcCtD
Anagrelide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00519	0.00519	CcSEcCtD
Anagrelide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00519	0.00519	CcSEcCtD
Anagrelide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00471	CcSEcCtD
Anagrelide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00465	CcSEcCtD
Anagrelide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00449	CcSEcCtD
Anagrelide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00434	CcSEcCtD
Anagrelide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00418	CcSEcCtD
Anagrelide—Rash—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00414	CcSEcCtD
Anagrelide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00414	CcSEcCtD
Anagrelide—Headache—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00411	CcSEcCtD
Anagrelide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0039	0.0039	CcSEcCtD
